TC Biopharm (Holdings) Plc
TCBP · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $10 | $14 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $10 | $14 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 94.3% | 0% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | – | 116.6% | -542.4% | -266% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -34.2% | -686.1% | -275.8% |
| EPS Diluted | -9.56 | -19.12 | -82,488 | -124 |
| % Growth | 50% | 100% | -66,422.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |